Natazia Kit
Product Images NDC 50419-409

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Natazia (NDC 50419-409). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bayer Healthcare Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Strcuture Ev (29132896 F94b 4680 Bff6 Eb95a585c43c 01)

Chemical structure of estradiol valerate, depicted as a steroid molecule with characteristic ring structures and a valerate ester side chain.*

FDA Label Image

Dienogest Chemical Structure (29132896 F94b 4680 Bff6 Eb95a585c43c 02)

Chemical structure of estradiol valerate, one of the active ingredients in Natazia. The diagram shows the molecular arrangement including labeled functional groups and stereochemistry relevant to the estrogen component of the drug.*

FDA Label Image

Figure 1 (29132896 F94b 4680 Bff6 Eb95a585c43c 03)

A line graph titled 'Median of MBL Volume by Cycle - Data from Study 308960' comparing median menstrual blood loss (MBL) volume in milliliters over seven cycles between a Natazia treatment group and a placebo group. The vertical axis shows median MBL volume in mL, and the horizontal axis shows Baseline and Cycles 1 through 7. Two lines represent the groups: the placebo group stays relatively high and declines slightly, while the Natazia group shows a significant decrease in median MBL volume over the cycles. Sample sizes for each cycle are displayed below the horizontal axis.*

FDA Label Image

Figure 2 (29132896 F94b 4680 Bff6 Eb95a585c43c 04)

A line graph titled "Median of MBL Volume by Cycle - Data from Study 308961" comparing median menstrual blood loss (MBL) volume over seven cycles between Natazia and placebo groups. The vertical axis shows median MBL in milliliters, and the horizontal axis displays treatment cycles from baseline through cycle 7. Two lines represent Natazia and placebo, with Natazia showing a significant decrease in median MBL volume over the cycles, while placebo remains relatively steady.*

FDA Label Image

Birth Control Methods Chart (29132896 F94b 4680 Bff6 Eb95a585c43c 05)

An illustration depicting various birth control methods ranked by pregnancy rate per 100 women per year. It shows fewer pregnancies associated with implants, injections, intrauterine devices, and sterilization at the top. Birth control pills, skin patch, and vaginal ring follow. Condoms and diaphragm are next, then abstinence during fertile days, spermicide, and withdrawal. No birth control is linked to the highest pregnancy rate.*

FDA Label Image

Blister Pack (29132896 F94b 4680 Bff6 Eb95a585c43c 06)

An illustrated medication chart for the Natazia estradiol valerate and estradiol valerate/dienogest kit. The chart shows 28 tablet positions arranged in four rows, indicating the order to start taking pills from left to right. It specifies tablet colors by position: dark yellow for positions 1-2, medium red for 3-7, light yellow for 8-24, dark red for 25-26, and white inert tablets for 27-28.*

FDA Label Image

Trade Carton (29132896 F94b 4680 Bff6 Eb95a585c43c 07)

Natazia kit packaging label showing the brand name and active ingredients estradiol valerate and estradiol valerate/dienogest. The label indicates the kit contains 2 mg/1 mg tablets and 2 mg/2 mg/3 mg/2 mg tablets, manufactured by Bayer HealthCare Pharmaceuticals Inc. The label is primarily light blue with brown and white sections and includes the Bayer logo.*

FDA Label Image

50419 0409 01 Splimage30 A619530a

Round, brown tablets embossed with a hexagon outline enclosing the letters "DD" on one side and plain on the other. These tablets correspond to Natazia, an oral contraceptive kit containing estradiol valerate and dienogest, produced by Bayer HealthCare Pharmaceuticals Inc.*

FDA Label Image

50419 0409 01 Splimage30 A91954ba

Round, brownish-red tablet with an imprint of a hexagon surrounding the letters "DJ" on one side, and a plain, unmarked opposite side. This image likely represents a tablet form of Natazia, a kit product containing estradiol valerate and estradiol valerate/dienogest, manufactured by Bayer HealthCare Pharmaceuticals Inc.*

FDA Label Image

50419 0409 01 Splimage30 Ac19560a

Natazia oral tablet imaged front and back showing a round, beige pill. The front side has a hexagon imprint with the letters 'DH' inside. The back side is plain. No strength or additional markings are visible.*

FDA Label Image

50419 0409 01 Splimage30 Af1957ba

Image shows two views of a round, reddish-brown tablet embossed with a hexagon enclosing the letters 'D N' on one side. The other side is plain with no markings. This tablet is part of the Natazia kit containing estradiol valerate and estradiol valerate/dienogest, manufactured by Bayer HealthCare Pharmaceuticals Inc.*

FDA Label Image

50419 0409 01 Splimage30 B219590a

Image shows two white round tablets side by side on a gray background. One tablet is embossed with a hexagon enclosing the letters 'DJ', while the other tablet is plain without any markings. These are individual tablets from the Natazia kit by Bayer HealthCare Pharmaceuticals Inc., containing estradiol valerate and estradiol valerate/dienogest.*

FDA Label Image

Image 01

A forest plot comparing effect estimates of oral contraceptive (COC) use on various health outcomes. The left panel lists study names and years, divided into 'Ever COC vs. Never COC Use' and 'Current COC use vs. Never-Use.' The middle section shows point estimates with confidence intervals across an effect estimate scale from -1.50 to 2.00. The right panel provides numerical values of odds ratios (OR), relative risks (RR), and hazard ratios (HR) with confidence intervals for each study.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.